Rasagiline
Rasagiline is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including Rasagiline, RASAGILINE. Available dosage form: tablet.
Drug Details
- Generic Name
- Rasagiline
- Brand Names
- Rasagiline, RASAGILINE
- Application Number
- NDA021641
- Sponsor
- Teva Pharmaceuticals USA, Inc.
- NDC Codes
- 16
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- RASAGILINE MESYLATE
Indications and Usage
1. INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD). Rasagiline tablets are monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson's disease ( 1 )